News
OPGN
--
0.00%
--
OpGen, Inc. Announces Notice of Annual Meeting Venue Change
GAITHERSBURG, Md., Sept. 18, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”) announced today that it has changed the venue of its 2020 Annual Meeting of Stockholders due to continuing health and safety considerations arising from the COVID-19 pandemic. As a result, the Company
GlobeNewswire · 3d ago
Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing
Published Study on Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance Presented Study on Long-Read Sequencing to Predict Phenotypic Antimicrobial Susceptibility Testing Results Work Aimed at Demonstrating Diagnostic Value of Next-Generation Sequencing for Antimicrobial Susceptibility
GlobeNewswire · 6d ago
OpGen Highlights Publication Of Study On 'Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance'
Published Study on Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance   Presented Study on Long-Read Sequencing to Predict Phenotypic Antimicrobial Susceptibility Testing Results Work
Benzinga · 6d ago
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
Ares Genetics nominated for the 40th Austrian Innovation Award by Federal Ministry for Digital and Economic Affairs ARESupa – Universal Pathogenome Assay nominated by expert jury for Austria’s most distinguished innovation awardVIENNA, Austria, and GAITHERSBURG, Md., Sept. 08, 2020 (GLOBE NEWSWIRE)
GlobeNewswire · 09/08 12:30
Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumonia
* Significant number of de-escalations (65.9%) could be made with high degree of clinical confidence when MRSA or Pseudomonas aeruginosa is not detected by the LRT Panel * Unyvero LRT Panel had consistently a very high negative predictive value (97.9%) * Unyvero LRT detected several key pathogens
GlobeNewswire · 09/02 12:30
OpGen Highlights Publication Of Clinical Study Demonstrating 'clinical utility of the Unyvero LRT panel'
Significant number of de-escalations (65.9%) could be made with high degree of clinical confidence when MRSA or Pseudomonas aeruginosa is not detected by the LRT Panel   Unyvero LRT Panel had consistently
Benzinga · 09/02 11:33
Overview Of Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.Benzinga Insights
Benzinga · 08/31 13:41
Hancock Jaffe Laboratories leads healthcare gainers: Organovo leads the losers
Gainers: Hancock Jaffe Laboratories (HJLI) +83%. Bio-Path Holdings (BPTH) +22%. Harpoon Therapeutics (HARP) +21%. Fluidigm (FLDM) +15%. Midatech Pharma (MTP) +13%.Losers: Organovo (ONVO) -10%. Akers Biosciences (AKER) -9%. Trevena (TRVN) -9%. OpGen (OPGN) -9%. Axcella Health
Seekingalpha · 08/21 15:03
PDD, GAN among premarket losers
Seeking Alpha - Article · 08/21 12:19
Return On Capital Employed Overview: OpGen
During Q2, OpGen's (NASDAQ: OPGN) reported sales totaled $1.19 million. Despite a 63.17% in earnings, the company posted a loss of $6.52 million. OpGen collected $616.93 thousand in revenue during Q1, but reported earnings showed a $3.99 million loss.What Is Return On Capital Employed? Return on
Benzinga · 08/20 18:26
IBIO, GEVO, OTRK and BLNK among midday movers
Gainers: Gevo (GEVO) +198%.OpGen (OPGN) +35%.FinVolution (FINV) +22%.AutoWeb (AUTO) +23%.Fathom Holdings (FTHM) +16%..Flux Power (FLUX) +16%.Ontrak (OTRK) +16%.CureVac (CVAC) +16%.China Liberal Education (CLEU) +15%Flotek Industries (FTK) +15%.Losers: Sypris Solutions (SYPR) -31%.Blink Charging (BLNK) -27%.Opera (OPRA) -21%.Teligent
Seekingalpha · 08/20 16:39
OpGen leads healthcare gainers; iBio and Can-Fite BioPharma among losers
Gainers: OpGen (OPGN) +28%. Kazia Therapeutics (KZIA) +14%. CureVac (CVAC) +14%. Ontrak (OTRK) +13%. Zosano Pharma (ZSAN) +12%.Losers: Teligent (TLGT) -18%. iBio (IBIO) -13%. Artelo Biosciences (ARTL) -11%. Can-Fite BioPharma (CANF) -9%. Allied Healthcare Products (AHPI)
Seekingalpha · 08/20 15:02
OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19
GlobeNewswire · 08/20 12:30
LB, MAG among premarket gainers
Kazia Therapeutics (KZIA) +31% on U.S. accelerated review tag for lead drug.OpGen (OPGN) +42% on launch of COVID-19 test in Europe.Allied Esports Entertainment (AESE) +14% on Esports betting licensing agreement with GRID.Streamline Health
Seekingalpha · 08/20 12:21
OpGen's stock soars after Curetis sub obtains CE mark certification in the EU for COVID-19 test
Shares of Maryland-based OpGen Inc. undefined rocketed 43% in active premarket trading Thursday, after the molecular diagnostics company said its...
MarketWatch · 08/20 12:06
OpGen up 53% on launch of COVID-19 test in Europe
Nano cap OpGen (OPGN) rallies 53% premarket on robust volume in reaction to its announcement that subsidiary Curetis GmbH has received CE Mark certification for its SARS-CoV-2 molecular test with PCR-compatible universal
Seekingalpha · 08/20 11:51
OpGen shares are trading lower after the company reported worse-than-expected Q2 sales results.
Benzinga · 08/13 12:18
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/13 01:45
OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire · 08/12 21:05
OpGen shares are trading higher after the company reported better-than-expected Q2 EPS results.
Benzinga · 08/12 20:14